Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY26.61 CNY
Change Today 0.00 / 0.00%
Volume 25.7M
600332 On Other Exchanges
Symbol
Exchange
600332 is not on other exchanges.
As of 3:05 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

guangzhou baiyunshan phar-a (600332) Snapshot

Open
CNY25.18
Previous Close
CNY26.61
Day High
CNY26.96
Day Low
CNY25.00
52 Week High
06/3/15 - CNY48.46
52 Week Low
08/26/15 - CNY24.00
Market Cap
31.8B
Average Volume 10 Days
29.0M
EPS TTM
CNY1.00
Shares Outstanding
1.1B
EX-Date
08/7/15
P/E TM
26.6x
Dividend
CNY0.28
Dividend Yield
1.05%
Current Stock Chart for GUANGZHOU BAIYUNSHAN PHAR-A (600332)

Related News

No related news articles were found.

guangzhou baiyunshan phar-a (600332) Related Businessweek News

No Related Businessweek News Found

guangzhou baiyunshan phar-a (600332) Details

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese and western patent medicines, chemical active pharmaceutical ingredients (API), natural medicine, biological medicines, chemical API intermediates, and other health products primarily in the People’s Republic of China. The company is also involved in the wholesale, retail, import, and export of western and Chinese pharmaceutical products, and medical apparatus; investment in health industry with healthcare, health management, health nursing, etc.; and production and sale of prepackaged food, dairy products, etc. As of December 31, 2014, it had 35 retail chain pharmacy outlets, including 34 outlets under the Cai Zhi Lin name and 1 pharmacy under the Ying Bang name. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was founded in 1997 and is based in Guangzhou, the People’s Republic of China.

12,546 Employees
Last Reported Date: 08/26/15
Founded in 1997

guangzhou baiyunshan phar-a (600332) Top Compensated Officers

Chairman and Chairman of Strategic Developmen...
Total Annual Compensation: --
Vice General Manager, Executive Director and ...
Total Annual Compensation: CNY966.1K
Vice-Chairman and Member of Budget Committee
Total Annual Compensation: CNY882.8K
Vice General Manager
Total Annual Compensation: --
Executive Director and Member of Budget Commi...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

guangzhou baiyunshan phar-a (600332) Key Developments

Guangzhou Pharmaceutical Co. Ltd. Announces Unaudited Consolidated and Company Cash Flow Results for the Six Months Ended June 30, 2015

Guangzhou Pharmaceutical Co. Ltd. announced unaudited consolidated and company cash flow results for the six months ended June 30, 2015. For the period, on consolidated basis the company reported net cash flows from operating activities of RMB 1,273,321,743.67 against RMB 1,167,005,247.62 a year ago. Cash paid to acquire fixed assets, intangible assets and other long-term assets was RMB 116,022,590.19 against RMB 211,209,894.56 a year ago. For the period, on company basis the company reported net cash flows from operating activities of RMB 291,576,644.35 against RMB 66,092,773.47 a year ago. Cash paid to acquire fixed assets, intangible assets and other long-term assets was RMB 9,124,837.30 against RMB 24,764,644.09 a year ago.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Board Meeting, Aug 20, 2015

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Board Meeting, Aug 20, 2015. Agenda: To consider proposal of signing framework agreement on cooperation with the Jining Health and Family Planning Commission, Shenzhen Cornerstone Entrepreneurial Investment Management Co., Ltd. and Jining High-tech Industrial Development Zone.

Hygiene and Family Planning Commission of Jining, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Shenzhen Costone Ventures Investment Management Company Limited and High and New Technology Industry Development Zone of Jining to Establish Cooperative Company

On 20 August 2015, Hygiene and Family Planning Commission of Jining, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Shenzhen Costone Ventures Investment Management Company Limited and High and New Technology Industry Development Zone of Jining entered into the Framework Agreement in relation to the establishment of a cooperative company whose business would include, among other things, investment in medical sector and management and services in medical sector, investment, operation and management in the basic facilities of medical organization and hire and leasing of medical equipment. Subject to the satisfaction of the conditions set out in the Framework Agreement, the company (or its related parties, such as subsidiaries or associated companies) will invest approximately RMB 1,000,000,000, representing approximately 33% of the equity interest of the Cooperative Company. After obtaining the necessary approvals, the Parties (or their respective related parties, such as subsidiaries or associated companies) shall sign, among other things, the Formal Agreement and the articles of association of the Cooperative Company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600332:CH CNY26.61 CNY 0.00

600332 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600332.
View Industry Companies
 

Industry Analysis

600332

Industry Average

Valuation 600332 Industry Range
Price/Earnings 25.9x
Price/Sales 1.7x
Price/Book 4.1x
Price/Cash Flow 21.5x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUANGZHOU BAIYUNSHAN PHAR-A, please visit www.gpc.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.